CONVERGENCE
of Laboratory Diagnostics and Population Health
8TH ANNUAL
CLINICAL LAB 2.0 WORKSHOP
March 3-4, 2025 • Pendry Chicago
Project Santa Fe Foundation’s
2025 CL2.0 Workshop
CONVERGENCE
Join lab industry leaders to explore the convergence of pathology, laboratory diagnostics and population health.
A HIGH-TOUCH, HIGHLY INTERACTIVE, LIMITED SEATING EVENT
We invite you to discover the latest evidence supporting laboratories' role in population health and cost avoidance, learn the roadmap for transitioning your clinical lab, and gain valuable insights across two days of exclusive collaboration and networking with laboratory thought leaders.
The potential value of the clinical lab does not end at the time we release a result — rather that’s where it begins.
Join Us at the Hotel Pendry Chicago
Recently Michelin rated, steeped in history, anchored in style, and set within the iconic 1929 Art Deco Carbide & Carbon building in Chicago’s loop neighborhood, Pendry Chicago is a modern luxury hotel that pays homage to both the past and the present.
You will find Pendry Chicago’s interiors contemporary and comfortable, designed with an eye for the Carbide & Carbon building’s illustrious Art Deco heritage and combined with a modern vision of luxury hospitality.
2025 CL2.0 Workshop Agenda
Join the crucial conversation with fellow leaders across the industry as we define the future business model for the clinical laboratory. Represented at this workshop is a tremendously respected collective body of knowledge, take your seat at the table and make an important contribution as critical questions are addressed that will shape the future of our collective industry.
More details on speakers and sessions to follow!
Sunday, March 2, 2025
5:30pm – 7:30pm: Welcome Reception
Join us for laid back networking as we welcome everyone to the beautiful Pendry Chicago.
Monday, March 3, 2025
7am – 8am: Breakfast
ACTIVATING THE CONSUMER
8am – 8:15am: Welcome to the Crucial Conversation!
Khosrow Shotorbani, MT(ASCP)
President, and CEO, Project Santa Fe Foundation
8:15am – 8:45am: Clinical Lab 2.0 Health Equity: Health Equity Requires Translating Laboratory Medicine & Pathology’s Value Beyond Test Volumes
Octavia M. Peck Palmer, PhD
Immediate Past President of ADLM, Vice Chair of Health Equity, Division Director, Clinical Chemistry, Associate Professor of Pathology, University of Pittsburgh Medical Center
The future of laboratory medicine and pathology lies in extracting actionable insights from the sea of clinical data labs already generate. Only through the intelligent use of this data can the traditional focus on lab testing volumes be shifted to achieve health equity across diverse populations and to advance patient care. With this approach, trends are revealed, gaps in healthcare access are identified, and the development of innovative algorithms can be supported, addressing disparities in patient care and outcomes. This evolution is necessary to pave the way for equitable healthcare for all.
8:45am – 10am: Engage: Consumer Activation
Facilitator: Octavia M. Peck Palmer, PhD
Immediate Past President of ADLM, Vice Chair of Health Equity, Division Director, Clinical Chemistry, Associate Professor of Pathology, University of Pittsburgh Medical Center
Role of the Consumer Driving Care
Cherise Shockley
Patient Advocate and Founder, Diabetes Social Media Advocacy
The Coming Healthcare Revolution
David W. Johnson
Chief Executive Officer, 4sight Health
FRAMING THE MOVEMENT
Clinical Lab 2.0 Committees in Action
Facilitator: James Crawford, MD, PhD
Professor and Chair Emeritus, Department of Pathology and Laboratory Medicine, Northwell Health
10:15am – 10:30am: Practicing Tomorrow’s Medicine—Clinical Lab 2.0 Driving "Transformational Care"
Myra Wilkerson, MD
Chair, Diagnostic Medicine Institute, Geisinger Health System
Multi-Institutional Demonstration Projects
Aya Haghamad, PharmD
Advisor, Pharmacy, Pathology Informatics, Northwell Health Labs
Assistant Professor, Dept. of Pathology and Laboratory Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health
Business/Alternative Payment Model
Lena Chaihorsky
Senior Vice President, Payor Innovation, Alva10 Inc.
Richard VanNess, MS
CoFounder, Wuscott
Pathology Informatics/Artificial Intelligence
Amjad Azizi
Director, Informatics Strategy and Solutions, Sysmex America
Ulysses G. J. Balis, MD, FCAP, FASCP
Associate Chief Medical Information Officer, University of Michigan
Education/Certification
Nancy Stratton, MBA
Chief Executive Officer, COLA
12:15pm – 1:15pm: Networking Lunch
TRANSITIONING FROM REACTIVE CONFIRMATION TO PROACTIVE PREDICTION
1:15pm – 1:30pm: National Kidney Foundation: Call to Action
Elizabeth Montgomery
VP, Learning Strategies, National Kidney Foundation
1:30pm – 1:45pm: Clinical Lab 2.0 Playbook: Convergence of Diagnostics and Population Health
Kathleen Swanson, MS, RPh
Project Manager, Pillar 3 Demonstration Projects, Project Santa Fe Foundation
1:45pm – 2pm: Clinical Lab 2.0 Initiated Population Health
Jennifer Houlihan, MSP
Vice President Enterprise Population Health, Atrium Health
2pm – 2:15pm: Clinical Lab 2.0 Change Management: Dual Transformation
Speaker to be announced soon
2:15pm – 3pm: Q&A and Group Discussion
Facilitator and panelists to be announced soon
INDUSTRY PARTNERING
3:15pm – 3:30pm: Clinical Lab 2.0 Demonstration Projects In Action
Kathleen Swanson, MS, RPh
Project Manager, Pillar 3 Demonstration Projects, Project Santa Fe Foundation
3:30pm – 5pm: Clinical Lab 2.0 in Industry Partnership - Industry Enablement
5pm – 5:30pm: Q&A and Group Discussion
Facilitator and panelists to be announced soon
5:30pm – 7:30pm: Evening Reception
Tuesday, March 4, 2025
7am – 8am: Breakfast
8am – 8:15am: Welcome Back!
Mark Fung, MD, PhD
Vice Chair for Population Health, University of Vermont Health Network
8:15am – 8:45am: Transitioning of Lab 1.0 to Lab 2.0: Dual Transformation Continued
Khosrow R. Shotorbani, MBA, MT(ASCP)
President, Executive Director, Project Santa Fe Foundation
8:45am – 10am: CL 2.0 Population Health and Acute Care - Unity/Volume of the Voices Amplifying the Movement: Future State Pathology and Clinical Lab Footprint
NAVIGATING GOVERNMENT AFFAIRS
10:30am – 12:00pm: Transitioning Times: Policy - Fireside Chat
Facilitator: William Morice II, MD, PhD
CEO, Mayo Clinical Laboratories
Nancy Stratton, MBA
CEO, COLA
Susan Van Meter
President, ACLA
12:00pm – 1pm: Lunch
FOLLOWING THE MONEY: ALTERNATIVE PAYMENT
1pm – 2:30pm: Follow the Money: Traction for Change
How laboratory services are reimbursed is rapidly changing; by 2030, for example, all Medicare beneficiaries will have risk-based care contracts. While traditional lab testing reimbursement continues to decline, bonus and risk-based payments for managing disease are actually increasing – reporting an A1C value is now worth 1/50th of the value of identifying a diabetic in your population!
In this session, expert panelists will:
- Explain the dramatic increase in value-based care payments and what this shift means for labs.
- Discuss the market opportunity for laboratories in value-based care by providing concrete examples.
- Offer a toolkit for how labs can:
- evaluate their internal finances
- while leveraging longitudinal data, identify opportunities to close care gaps
- obtain payment for addressing those care gaps
Facilitator: Lena Chaihorsky
Senior Vice President, Payor Innovation, Alva10 Inc.
Renee Ennis, MBA, FHFMA
Former CFO, Rhodes Group, TriCore Reference Labs, Presbyterian Healthcare Services
Roy Gandolfi, MD
Medical Director, Select Health/Intermountain Healthcare
Joseph Schulman
Senior Vice President, Value Based Strategy, Northwell Health
Glen Schuster
President, Chief Executive Officer, VedaPointe
2:30pm - 3pm: Call to Action